Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Prescriptions of the newer anti-hyperglycemic agents continue to stagnate, even among eligible patients [19], which may be related, at least in part, to the uncertainty about the optimal clinical management of T2D
GLP-1 Discontinuation Rates in Type 2 Diabetes "Using insurance records from more than 60,000 Americans with type 2 diabetes, we found that about 4 in 10 patients stopped their GLP-1 medication within the first year, and nearly 6 in 10 had stopped by the end of two years," Sontha said
(44) Future Research Directions Long-Term Cardiovascular and Renal Data: Further studies are required to evaluate long-term cardiovascular outcomes and renal protection beyond the current trial information
Diabetic Eye Disease
.jpg)
US$ 28.93
US$ 25.89
US$ 23.22
